http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-37048-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e77f06144be4708a6ae75bd9fee56a4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J7-0055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
filingDate 1972-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1973-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-37048-L
titleOfInvention 21-alkylated- 3, 20-diketo-delta 4-steroids.
abstract 1416427 21-Alkylpregnanes AKZO NV 5 Jan 1973 [12 Jan 1972] 1534/72 Heading C2U The invention comprises compounds of formula wherein X is H or halo; Y is H 2 , oxo, H(OH), H(OAcyl) or H(halo); R 1 is H, Me or halo; R 2 is C 1-4 alkyl; R 3 is H or R 2 ; R 4 is H (except when Y is H 2 ), OAcyl, OAlkyl or Me; R 5 is H or C 1-4 alkyl, at least one of R 4 and R 5 being alkyl; and the 1,4- and 6,7-bonds are each saturated or unsaturated. Compounds I are prepared by 21-mono- or di-alkylation of compounds of formula (wherein A is a protected hydroxyl or oxo radical; B is H or a protected hydroxyl group; R<SP>1</SP> 4 is R 4 or OH; and R 7 is H, halo or C 1-4 alkyl) or, in Ex. 19, the 16α,17α-dimethylpregna - 1,4 - diene - 3,20 - dione, and where appropriate converting the alkylated product (which may or may not itself be a compound I) into a compound I by one or more appropriate reactions selected from: (i) elimination of 11α- mesyloxy to give #<SP>9(11)</SP>; (ii) conversion of #<SP>9(11)</SP> into 9α-halo-11#-OH or 9α,11#-dihalo, optionally via 9#,11#-epoxy intermediates; (iii) hydrolysis of protected hydroxy groups at position 3 or 11; (iv) hydrolysis of a protected oxo group at position 3 (with concurrent rearrangement of any #<SP>5</SP> or #<SP>3,5</SP> to #<SP>4</SP>); (v) acylation of 11-OH; (vi) oxidation of 3- or 11-OH to oxo; (vii) #<SP>1</SP>, #<SP>4</SP> and/or #<SP>6</SP>-dehydrogenation using microorganisms, quinones, selenium dioxide or halogenation and dehydrohalogenation; (viii) 11- microbial hydroxylation; (ix) reduction of 9α-Br to H; (x) acid or base-induced epimerization of a 6-substituent from # to α; (xi) 3-hydroxy (or acyloxy) - #<SP>5</SP>#3 - hydroxy (or acyloxy) - 5α,6α- epoxy#3 - hydroxy (or acyloxy) - 5a - hydroxy- 6# - fluoro (or methyl)#3 - oxo - 5α - OH - 6#- fluoro (or methyl)##<SP>4</SP> - 3 - oxo - 6# - fluoro (or methyl). The aforesaid 21-alkylation may be effected (a) by a Mannich reaction to introduce a 21 - (substituted aminomethyl) group which is quaternized and then reacted with a base to give a 21-methylene group which is either reduced to 21-methyl or converted by a Grignard reaction to another 21-alkyl group, or (b) by enolizing the 20-oxo group with trityllithium, a lithium dialkylamide, a Grignard reagent, or an alkali metal or amide thereof in liquid ammonia, followed by reaction with an alkyl halide. Method (b) may yield a mono- or di-alkylated product depending on the reactants and reaction conditions, and may additionally alkylate any 3- or 17-OH group in the starting material or convert an 11#-acetoxy group into a propionyloxy or isobutyryloxy group. 3 - Ethoxy - 16α,17α - dimethylpregna - 3,5- dien-20-one is prepared by enol-esterification of the corresponding #<SP>4</SP>-3,20-dione (Ex. 17). Antiinflammatory compositions for topical, rectal and parenteral administration comprise a compound I and a carrier.n[GB1416427A]
priorityDate 1972-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396423
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414635703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3028194
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222

Total number of triples: 30.